Blood & Cancer

Blood & Cancer

www.mdedge.com/hematology-oncology
Hematology/Oncology from MDedge


VTE rate, “COVID toes,” and Virchow’s triad: What you need to know about COVID and coagulation
May 21 • 32 min
Adam C. Cuker, MD, joins host David H. Henry, MD, to discuss recent findings regarding coagulation in COVID-19 patients. Both and both practice at the Hospital of the University of Pennsylvania in Philadelphia. Dr. Cuker cited data suggesting at…
Dr. Matt Watto of The Curbsiders on being an internist in the COVID-19 pandemic
May 14 • 31 min
In this episode, Matthew Watto, MD, an internist at Pennsylvania Hospital in Philadelphia, tells host David H. Henry, MD, also of Pennsylvania Hospital, how the COVID-19 pandemic has affected him personally and professionally. recounts how COVID-19…
Treating genitourinary malignancies in the COVID-19 era
May 7 • 34 min
How should oncologists be treating genitourinary malignancies during the COVID-19 pandemic? , of McMaster University in Hamilton, Ontario, and colleagues recently published recommendations that help answer that question (). In this episode, Dr. Lalani…
The first virtual ASCO meeting; plus Part 2 of tech tools for docs
Apr 30 • 37 min
The American Society of Clinical Oncology is gearing up for its first-ever virtual meeting at the end of May 2020. ASCO’s president , joins , of Pennsylvania Hospital, Philadelphia, to explain how the virtual meeting will work, from releasing…
Treating colorectal cancer in the COVID-19 era
Apr 23 • 39 min
Oncologists are now weighing the benefits of treating cancer patients against the risk of exposing them to SARS-CoV-2. , of University of Oxford (England) talks with podcast host , of Pennsylvania Hospital in Philadelphia, about how to treat…
COVID-19 and the community oncologist
Apr 16 • 38 min
How are community oncologists adapting to the COVID-19 pandemic? Podcast host , of Pennsylvania Hospital in Philadelphia, explores this question with , of Willamette Valley Cancer Institute (WVCI) and Research Center in Eugene, Ore. Dr. Lonergan…
COVID-19 and lung cancer: The decision to delay treatment
Apr 9 • 33 min
In the “new normal” of treating cancer patients during COVID-19, when do you decide to start treatment or pause it? Narjust Duma, MD, a thoracic oncologist at the University of Wisconsin, Madison, shares how she makes those decisions in…
Bonus: COVID-19 critical-care lessons from Seattle
Apr 7 • 26 min
As the nation’s health care system braces for COVID-19 cases, physicians who’ve faced the pandemic first have critical lessons for everyone. In this bonus episode, two Seattle-area critical care leaders explain how their medical centers are…
COVID-19: ‘The world has changed’
Apr 2 • 31 min
Zainab Shahid, MD, medical director of bone marrow transplant infectious diseases at the Levine Cancer Institute/Atrium Health in Charlotte, N.C., breaks down when cancer patients should seek testing for COVID-19 and how they should be treated. also…
Grands rounds in the age of COVID-19; cardiotoxicity in breast cancer
Mar 26 • 32 min
Susan Dent, MD, codirector of the cardio-oncology program at Duke University in Durham, N.C., reflects on virtual grand rounds, telehealth, the screening of patients before clinic visits, and other new realities of cancer care in the age of COVID-19. …
Tech tools for docs: Apps, sites, and software in the virtual world
Mar 19 • 32 min
David Henry, MD, welcomes Bernard A. Mason, MD, to discuss Dr. Mason’s favorite digital tools for working as a physician in part 1 of 2. Dr. Mason is an oncologist with the Pennsylvania Hospital and the University of Pennsylvania, both in…
Common bleeding and coagulation issues
Mar 12 • 30 min
There’s an art to taking a thorough bleeding history. In this episode, , director of the Hemophilia and Thrombosis Center at the University of Pennsylvania, Philadelphia, shares the most important questions to ask and the challenges in assessing…
Is this a good study? The statistics tell the story
Mar 5 • 31 min
Ever read through a study and wondered how to apply the hazard ratio, or if you should change your practice because of a secondary endpoint finding? In this episode, , of the University of Pennsylvania, Philadelphia, explains all the common terms and…
Treatment approaches in AML
Feb 27 • 32 min
A diagnosis of acute myeloid leukemia (AML) was once an emergency, requiring immediate treatment. Today, the need to start treatment is still urgent, but many patients can benefit by waiting a few days for testing to reveal a fuller picture of the…
Treatment tips in CLL
Feb 20 • 22 min
The million-dollar question in the treatment of chronic lymphocytic leukemia (CLL) is what to do after a patient relapses following treatment with venetoclax. , and , both of Memorial Sloan Kettering in New York, join podcast host , of Pennsylvania…
When to refer for CAR T-cell therapy
Feb 13 • 21 min
Chimeric antigen receptor (CAR) T-cell therapy is one of the hottest advances in lymphoma treatment, but who should get it and what does the process look like? , of the Cleveland Clinic helps answer those questions on the podcast. She joins Blood…
Understanding biosimilars
Feb 6 • 19 min
Think of biosimilars as your mother’s minestrone soup: It’s the same recipe and ingredients every time, but not every batch is chemically identical, even if it tastes about the same. That’s how Brian T. Hill, MD, PhD, of the Cleveland Clinic,…
ASH19 special report
Jan 30 • 30 min
Blood & Cancer takes you behind the podium at the American Society of Hematology annual meeting for an in-depth look at the latest developments in anemia and myelodysplastic syndrome, chimeric antigen receptor (CAR) T-cell therapy for mantle cell…
Sickle cell update: Treating pain and progress toward cure
Jan 23 • 25 min
When it comes to treating pain related to sickle cell disease, consider the underlying factors, from constipation to compression spine deformity. That’s just some of the advice from Ifeyinwa Osunkwo, MD, of Atrium Health and Levine Cancer Institute…
Practice-changing research in GI cancer
Jan 16 • 24 min
, of the University of Pennsylvania, Philadelphia, joins Blood & Cancer host , also of the University of Pennsylvania, to review the top three GI cancer trials presented at the 2019 ESMO World Congress on Gastrointestinal Cancer, and how they are…
Palliative care: Not just another word for hospice
Jan 9 • 34 min
, of Duke Cancer Institute in Durham, N.C., joins host , of Pennsylvania Hospital, Philadelphia, to discuss the evolution of the palliative care field and some of the underrecognized ways that it can improve care for hematology-oncology patients….
The best of Clinical Correlation
Jan 2 • 15 min
In this special edition podcast, we bring you the best of Clinical Correlation, a segment on the human side of hematology-oncology care. Clinical Correlation is written, recorded, and produced by , of Stanford (Calif.) University. This episode…
ICYMI: Get to know Dr. Ilana Yurkiewicz
Dec 26, 2019 • 36 min
In this special edition podcast, Blood & Cancer revisits an interview with , of Stanford (Calif.) University. Dr. Yurkewicz is the writer and producer of the podcast’s Clinical Correlation segment, which puts a human face on hematology-oncology…
ASCO president on uniting the oncology field
Dec 19, 2019 • 22 min
, chief medical officer of Sarah Cannon Cancer Institute in Nashville, Tenn., joins the podcast to talk about what it’s like to be the 2019-2020 president of the American Society of Clinical Oncology. Dr. Burris joins Blood & Cancer host , of…
2019 drug approvals in hematology-oncology
Dec 12, 2019 • 21 min
, of the University of Pennsylvania, Philadelphia, joins the podcast to discuss noteworthy drug approvals in hematology-oncology in 2019. Dr. Mintzer and Blood & Cancer host, , of Pennsylvania Hospital, Philadelphia, discuss what these new…
ASH 2019 Preview: Potentially practice-changing studies
Dec 5, 2019 • 39 min
, of the Cleveland Clinic joins Blood & Cancer host , MD, of Pennsylvania Hospital, Philadelphia, to preview the potentially practice changing research that will be reported at the 2019 annual meeting of the American Society of Hematology. Plus,…
Breaking down biosimilars: ICYMI
Nov 28, 2019 • 28 min
In this special edition podcast, Blood & Cancer revisits an interview with , of Fred Hutchinson Cancer Research Center, Seattle, on defining and understanding biosimilars. Dr. Lyman joins host , to explore the interchangeability of these drugs and…
Breast cancer case review with Dr. Jame Abraham
Nov 21, 2019 • 29 min
, of the Cleveland Clinic joins Blood & Cancer host , MD, of Pennsylvania Hospital, Philadelphia to review two cases of breast cancer, focusing on when to use the 21-gene breast recurrence score and how to apply the results. Plus, in…
Immunotherapy in lung cancer with Dr. Jack West, Part 2
Nov 14, 2019 • 28 min
, joins the podcast to discuss the immunotherapy in the treatment of lung cancer. Dr. West is an associate clinical professor in medical oncology at City of Hope Comprehensive Cancer Center in Duarte, Calif., and a thought leader in thoracic oncology….
Immunotherapy in lung cancer with Dr. Jack West, Part 1
Nov 7, 2019 • 29 min
, joins the podcast to discuss the latest trials of immunotherapies in the treatment of lung cancer. Dr. West is an associate clinical professor in medical oncology at City of Hope Comprehensive Cancer Center in Duarte, Calif., and a thought…
Reader beware: Interpreting post hoc analyses
Oct 31, 2019 • 22 min
, of McMaster University, Hamilton, Ont., and the University of Toronto, joins Blood & Cancer host , of Pennsylvania Hospital, Philadelphia, to explain what a post hoc analysis is and why it should be interpreted with caution. Plus, in Clinical…
Delivering bad news to patients
Oct 24, 2019 • 26 min
Strategies and guidelines for delivering bad news to patients from David Henry, MD, and Ilana Yurkiewicz, MD. Timestamps: This week in Oncology (01:30) Conversation (04:22) This week, the host of Blood & Cancer and the writer, producer,…
Choosing a melanoma therapy with Dr. Justine Cohen
Oct 17, 2019 • 30 min
, of the University of Pennsylvania, Philadelphia, joins Blood & Cancer host , also of the University of Pennsylvania, to discuss a recent melanoma case in the adjuvant setting and when to consider targeted therapies or immune checkpoint…
‘What would you do if this were your family member?’
Oct 10, 2019 • 24 min
In this edition, we conclude our about having hard conversations with patients as a trainee. This week’s case poses the following question: “What would you do if this were your family member?” Ilana Yurkiewicz, MD, Blood & Cancer cohost and…
Ending curative therapy even when the family wants it
Oct 3, 2019 • 18 min
Hematology/oncology requires clinicians to have some of the most difficult conversations in all of medicine. In part 2 of our 3-part series, we tackle how to talk about ending curative therapy even when the family wants to keep going. These…
‘How long do I have left?’ Difficult conversations for trainees (part 1)
Sep 26, 2019 • 21 min
Hematology/oncology requires clinicians to have some of the most difficult conversations in all of medicine. In this edition, we begin a three-part series about having those conversations. These conversations will be hosted by Ilana Yurkiewicz,…
Updated ASCO guidelines for VTE in cancer
Sep 19, 2019 • 32 min
, of the Cleveland Clinic joins Blood & Cancer host , of Pennsylvania Hospital, Philadelphia, to break down the latest recommendations from the American Society of Clinical Oncology on venous thromboembolism (VTE) prophylaxis in cancer…
Castleman disease: Dr. David Fajgenbaum chases his cure
Sep 12, 2019 • 37 min
, of the University of Pennsylvania, Philadelphia, is a pioneer in the research of Castleman disease and he’s a patient himself. He joins Blood & Cancer host , of Pennsylvania Hospital, Philadelphia, to talk about the presentation of Castleman,…
Decoding the mystery of the meta-analysis
Sep 5, 2019 • 30 min
, of McMaster University, Hamilton, Ont., and the University of Toronto, joins Blood & Cancer host , of Pennsylvania Hospital, Philadelphia, to talk about meta-analyses and what they really tell us about the evidence for treatment. Plus, in…
GI malignancy case review
Aug 29, 2019 • 29 min
, of the University of Pennsylvania, Philadelphia, joins Blood & Cancer host , also of the University of Pennsylvania, to discuss two real-world gastrointestinal cancer cases and how the latest research should influence the approach to care. Plus,…
ASCO 2019 Breast Cancer Update
Aug 22, 2019 • 33 min
, of Feinberg School of Medicine and Northwestern Medicine in Chicago, chats with , host of Blood & Cancer, to review some of the top breast cancer research presented at the 2019 annual meeting of the American Society of Clinical Oncology….
Geriatric oncology
Aug 15, 2019 • 34 min
, of Northwestern University in Chicago, joins Blood & Cancer as the guest host for a conversation with , MS, of the University of Rochester in N.Y., on geriatric oncology and the best tools to assess the fitness of older patients with…
The pitfalls of P values
Aug 8, 2019 • 30 min
, of McMaster University, Hamilton, Ont., and the University of Toronto, joins Blood & Cancer host , of Pennsylvania Hospital, Philadelphia, to explain what P values actually measure and how they both help and hinder the interpretation of clinical…
Cancer trials in the community
Aug 1, 2019 • 35 min
, of Levine Cancer Institute at Atrium Health in Charlotte, N.C., chats with , host of Blood & Cancer, about how to perform clinical trials in the community oncology setting. Plus, in Clinical Correlation, , of Stanford (Calif.) University,…
Polypharmacy in older cancer patients
Jul 25, 2019 • 32 min
, of the Jefferson College of Pharmacy at Thomas Jefferson University in Philadelphia chats with , host of Blood & Cancer, about the definition of polypharmacy and the challenges it poses in treating older cancer patients. Plus, in Clinical…
Pancreatic cancer and clinical trials
Jul 17, 2019 • 24 min
Pancreatic cancer and clinical trials , host of Blood & Cancer, is on location at the 2019 annual meeting of the American Society of Clinical Oncology during this podcast, speaking with , of the Cleveland Clinic. Dr. Sohal presented…
Financial toxicity of cancer; the illusion of treatment options
Jul 11, 2019 • 24 min
How the cost of care is impacting how patients go through a diagnosis of cancer
Emergency Oncology: ICYMI
Jul 5, 2019 • 26 min
An interview that predates Blood & Cancer with Dr. Maura Sammon
Bloodless medicine, iron deficiency, and ASCO reflections
Jun 27, 2019 • 21 min
Episode 24
ASCO 2019 Special
Jun 22, 2019 • 38 min
A round-up from the annual meeting of the American Society of Clinical Oncology 2019
Welcome to Cancerland with David Scadden, MD
Jun 20, 2019 • 39 min
The official podcast of MDedge Hematology Oncololgy
Patient-reported outcomes in cancer
Jun 13, 2019 • 30 min
Episode 21
Ask about constipation, calling patients in the middle of the night
Jun 6, 2019 • 35 min
Pearls for oncologists and hematologists
BONUS: Get to know Ilana Yurkiewicz, MD
Jun 4, 2019 • 36 min
Writer, Producer, and host of Clnical Correlation opens up about her career and her passion
Cancer-related fatigue
May 30, 2019 • 33 min
Episode 18
Hazard ratio? P value?
May 23, 2019 • 27 min
What statistics mean in practice for oncologists, hematologists, and healthcare professionals
Lung cancer: PD, PDL-1, and immunotherapy
May 16, 2019 • 35 min
Clinical pearls and insight on patients with lung cancer
ITP: When and how, pregnant patients
May 9, 2019 • 31 min
Causes and treatments of Idiopathic thrombocytopenic purpura from a Harvard Professor and Mass General Hematologist
CAR T-cell therapy: Development to access
May 2, 2019 • 32 min
Clinical pearls, insights, and perspective in hematology and oncology care
ASCO GI 2019
Apr 25, 2019 • 21 min
New data for the clinical oncologist from ASCO 2019
Drug development stats and research
Apr 18, 2019 • 26 min
Oncology and hematology news for clinical healthcare professionals.
Anemia in cancer
Apr 11, 2019 • 27 min
The official podcast of MDedge Hematology/Oncology
Breast Cancer, CDK4/6 Inhibitors
Apr 4, 2019 • 30 min
You can contact Blood & Cancer at podcasts@mdedge.com and you can follow us on Twitter at @mdedgeHemOnc. Richard Finn, MD, of the Geffen School of Medicine at UCLA joins guest host Jame Abraham, MD, of the Cleveland Clinic to talk about CDK4/6 inhibitors…
Sickle Cell Treatment, Part II
Mar 28, 2019 • 18 min
Episode 09: Part II of a conversation with guest host, Ify Osunkwo, MD, on sickle cell treatment. Ilana Yurkiewicz explores patients hoping for the best but expecting the worst.
Sickle Cell Treatment, Part I:
Mar 21, 2019 • 25 min
Contact us: podcasts@mdedge.com Twitter: @MDedgeHemOnc In this episode, John J. Strouse, MD, PhD, and Julie Kanter, MD, join guest host Ify Osunkwo, MD, of Irvine Cancer Institute/Atrium Health in Charlotte, N.C., to discuss current therapies for sickle…
Lymphoma in patients w/ HIV
Mar 14, 2019 • 24 min
Stefan K. Barta, MD, of the University of Pennsylvania, joins David Henry, MD, to discuss the treatment and diagnosis of lymphoma in patients with HIV. In Clinical Correlation, Ilana Yurkiewicz, MD, has Part 2 of her discussion on informed consent in…
Anticoagulation in cancer
Mar 7, 2019 • 30 min
Thursday, March 7, 2019
KATHERINE trial and breast cancer
Feb 28, 2019 • 25 min
, of Virginia Commonweath University joins guest host , of the Cleveland Clinic to discuss the KATHERINE trial and its impact on the treatment of HER2-positive breast cancer. And , talks about whether it’s better for physicians to be vague about…
How to read and review scientific papers
Feb 21, 2019 • 20 min
Concact us: podcasts@mdedge.com In this episode, Danial G. Haller, MD, of the University of Pennsylvania joins David H. Henry, MD, to talk about the best ways to read and review scientific literature. And Ilana Rachel Yurkiewicz, MD, talks about chaos and…
ESMO 2018 and more
Feb 14, 2019 • 23 min
Concact us: podcasts@mdedge.com (Please let us know what you think about transcripts or written versions of Dr. Henry’s conversations). In this episode, David Henry, MD, welcomes Daniel G. Haller, MD, to rehash research from ESMO 2018 as well as the way…
Biosimilars: Gary Lyman
Feb 7, 2019 • 29 min
Contact us: podcasts@mdedge.com MDedge Hematology/Oncology Twitter: @MDedgeHemOnc Ilana Yurkiewicz Twitter: @ilanayurkiewicz In this episode, Gary H. Lyman, MD joins David Henry, MD, to talk about biosimilars. Dr. Lyman talks about the definition of…
Antiemetics: Richard Gralla
Jan 31, 2019 • 27 min
In the first episode of Blood & Cancer, David Henry, MD (http://bit.ly/2MFDfzm), welcomes Richard J. Gralla, MD (http://bit.ly/2ShsxEv), or the Albert Einstein College of Medicine in New York. The topic today centers around antiemetics and ways to use…
The JCSO Interview: Dr. Maura Sammon
Aug 7, 2018 • 17 min
When cancer patients present to the emergency department with symptoms and say they’re being treated for cancer, it’s crucial for the attending physician to ascertain at the outset if the treatment is with chemotherapy or immunotherapy so that the…
David Henry’s JCSO podcast, May - June 2018
Aug 3, 2018 • 14 min
In his bimonthly podcast, Dr Henry, the JCSO Editor-in-Chief, discusses a round-up by JCSO Editor Dr Howard Burris of the top takeaways from this year’s annual ASCO meeting, as well as a series of articles focusing on CAR T-cell therapies. He also…
David Henry’s JCSO podcast, March - April 2018
Aug 1, 2018 • 12 min
In his bimonthly podcast, Dr Henry, the JCSO Editor-in-Chief, discusses a round-up by JCSO Editor Dr Howard Burris of the top takeaways from this year’s annual ASCO meeting, as well as a series of articles focusing on CAR T-cell therapies. He also…
JCSO Interview with Dr Daniel Haller
Mar 29, 2018 • 26 min
In this interview, Dr David Henry, the Editor-in-Chief of The Journal of Community and Supportive Oncology, and Dr Daniel Haller of the Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine in Philadelphia, discuss recent…
JCSO Interview with Dr. Kenneth Anderson
Mar 27, 2018 • 31 min
In this interview, Dr David Henry, the Editor-in-Chief of The Journal of Community and Supportive Oncology, and Dr Ken Anderson, the Kraft Family Professor of Medicine at Harvard Medical School and an international thought leader and investigator in…
JSCO Podcast January - February 2018
Mar 23, 2018 • 15 min
In this podcast, Dr Henry highlights research articles on analgesic management in radiation oncology for painful bone metastases, hospitalizations for fracture in patients with metastatic disease, measurement of physical activity and sedentary…